|
|
||||||||
Sign In to gain access to subscriptions and/or personal tools. |
|||||||||
Articles |
A study was conducted to measure breast milk concentrations of fluoxetine and its active metabolite, norfluoxetine, excreted in breast milk in a cohort of nursing women using fluoxetine, and to estimate infant dose from nursing. The study included 10 women nursing 11 infants (median age, 185 days). The mean fluoxetine dose was 0.39 mg/kg/day. Each patient manually collected 3 to 6 milk samples throughout a dosing interval. Concentrations of fluoxetine and norfluoxetine in milk were measured by gas-liquid chromatography. Mothers reported whether they observed adverse effects in their infants. The average infant doses of fluoxetine and norfluoxetine, as estimated for an exclusively breast-fed infant ingesting 1000 mL of milk per day, were 0.077 mg (SD = 0.054 mg) and 0.084 mg (SD = 0.043 mg), respectively. The total dose of fluoxetine and norfluoxetine (expressed as fluoxetine equivalents) was 0.165 mg (SD = 0.092 mg), which was equivalent to 10.8% (SD = 2.2%) of the maternal dose, adjusted on a mg/kg basis in a 4-kg infant. No adverse events were reported by mothers in their infants. Approximately one tenth of the adult therapeutic dose of fluoxetine is excreted in breast milk. Although short-term adverse effects in the infant from exposure through nursing were not reported in this cohort, future studies that assess the potential long-term consequences are needed.
This article has been cited by other articles:
![]() |
ACOG Practice Bulletin Clinical Management Guidelines for Obstetrician-Gynecologists Use of Psychiatric Medications During Pregnancy and Lactation Focus, July 1, 2009; 7(3): 385 - 400. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kohen Psychotropic medication and breast-feeding Adv. Psychiatr. Treat., September 1, 2005; 11(5): 371 - 379. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. F. Oberlander, R. E. Grunau, C. Fitzgerald, M. Papsdorf, D. Rurak, and W. Riggs Pain Reactivity in 2-Month-Old Infants After Prenatal and Postnatal Selective Serotonin Reuptake Inhibitor Medication Exposure Pediatrics, February 1, 2005; 115(2): 411 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Weissman, B. T. Levy, A. J. Hartz, S. Bentler, M. Donohue, V. L. Ellingrod, and K. L. Wisner Pooled Analysis of Antidepressant Levels in Lactating Mothers, Breast Milk, and Nursing Infants Am J Psychiatry, June 1, 2004; 161(6): 1066 - 1078. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gjerdingen The Effectiveness of Various Postpartum Depression Treatments and the Impact of Antidepressant Drugs on Nursing Infants J Am Board Fam Med, September 1, 2003; 16(5): 372 - 382. [Abstract] [Full Text] |
||||
![]() |
V. Hendrick and L. Altshuler Management of Major Depression During Pregnancy Am J Psychiatry, October 1, 2002; 159(10): 1667 - 1673. [Full Text] [PDF] |
||||
![]() |
T. W. Hale, S. Shum, and M. Grossberg Fluoxetine Toxicity in a Breastfed Infant Clinical Pediatrics, December 1, 2001; 40(12): 681 - 684. [PDF] |
||||
![]() |
V. HENDRICK, L. ALTSHULER, A. WERTHEIMER, and W. A. DUNN Venlafaxine and Breast-Feeding Am J Psychiatry, December 1, 2001; 158(12): 2089 - 2090. [Full Text] |
||||
![]() |
N. Epperson, K. A. Czarkowski, D. Ward-O'Brien, E. Weiss, R. Gueorguieva, P. Jatlow, and G. M. Anderson Maternal Sertraline Treatment and Serotonin Transport in Breast-Feeding Mother-Infant Pairs Am J Psychiatry, October 1, 2001; 158(10): 1631 - 1637. [Abstract] [Full Text] [PDF] |
||||
![]() |
Committee on Drugs The Transfer of Drugs and Other Chemicals Into Human Milk Pediatrics, September 1, 2001; 108(3): 776 - 789. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Winans Antidepressant Use During Lactation J Hum Lact, August 1, 2001; 17(3): 256 - 261. [Abstract] [PDF] |
||||
![]() |
V. HENDRICK, A. FUKUCHI, L. ALTSHULER, M. WIDAWSKI, A. WERTHEIMER, and M. V. BRUNHUBER Use of sertraline, paroxetine and fluvoxamine by nursing women The British Journal of Psychiatry, August 1, 2001; 179(2): 163 - 166. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. K. Burt, R. Suri, L. Altshuler, Z. Stowe, V. C. Hendrick, and E. Muntean The Use of Psychotropic Medications During Breast-Feeding Am J Psychiatry, July 1, 2001; 158(7): 1001 - 1009. [Abstract] [Full Text] |
||||
![]() |
S. Ito Drug Therapy for Breast-Feeding Women N. Engl. J. Med., July 13, 2000; 343(2): 118 - 126. [Full Text] [PDF] |
||||
![]() |
Z. N. Stowe, L. S. Cohen, A. Hostetter, J. C. Ritchie, M. J. Owens, and C. B. Nemeroff Paroxetine in Human Breast Milk and Nursing Infants Am J Psychiatry, February 1, 2000; 157(2): 185 - 189. [Abstract] [Full Text] |
||||
![]() |
C. D. Chambers, P. O. Anderson, R. G. Thomas, L. M. Dick, R. J. Felix, K. A. Johnson, and K. L. Jones Weight Gain in Infants Breastfed by Mothers Who Take Fluoxetine Pediatrics, November 1, 1999; 104(5): 61e - 61. [Abstract] [Full Text] |
||||
![]() |
K. Yoshida, B. Smith, and R. Kumar Psychotropic drugs in mothers' milk: a comprehensive review of assay methods, pharmacokinetics and of safety of breast-feeding J Psychopharmacol, January 1, 1999; 13(1): 64 - 80. [Abstract] [PDF] |
||||
![]() |
N. B. Brent and K. L. Wisner Fluoxetine and Carbamazepine Concentrations in a Nursing Motier/Infant Pair Clinical Pediatrics, January 1, 1998; 37(1): 41 - 44. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |